SureTrader SureTrader
Home > Boards > US Listed > Biotechs >


Add CRYO Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 10/21/2016 1:07:20 PM - Followers: 8 - Board type: Free - Posts Today: 0

American CryoStem Corporation (OTCQB: CRYO) is a pioneer in the fields of Regenerative and Personalized Medicine, American CryoStem is a developer, marketer and global licensor of patented adipose tissue-based cellular technologies and related proprietary services with a focus on clinical processing, commercial bio-banking and application development for adipose (fat) tissue and autologous adipose-derived regenerative cells (ADRCs). The Company maintains a strategic portfolio of intellectual property and patent applications that form its Adipose Tissue Processing Platform, which supports and promotes a growing pipeline of biologic products and processes, clinical services and international licensing opportunities. Through its ACS Laboratories division, the Company operates an FDA registered, cGMP compliant human tissue processing, cryo-storage, cell culture and differentiation media development facility in Mount Laurel, New Jersey.

For more information, please visit and

Corporate Lab Facility in New Jersey

Adipose Tissue Processing Platform

American CryoStem has invested heavily over the past five years to develop and bring to market our proprietary, validated, turn-key FDA registered laboratory for Adipose Tissue Processing. The clinical processing platform enables us to cryopreserve an individual’s adipose tissue (fat) or process it into the Stromal Vascular Fraction (SVF), which contains adipose-derived regenerative cells (ADRCs) growth factors and other regenerative cells, including white blood cells, endothelial cells, smooth muscle cells, pericytes, fibroblasts and pre-adipocytes, among others. The Company’s Platform is centered on enabling affordable, end-to-end, clinical collection, processing, tracking and storage of adipose tissue and ADRCs. Stored tissue may be retrieved for immediate use in cosmetic and reconstructive surgery of the face, hands, breasts and buttocks; further processing and delivery of a cellular sample for use in topical or orthopedic applications; or processing and expansion for direct or IV injection for cell therapy treatments.

In addition to implementing strategies to drive rapid, exponential growth of its Cellular Processing and Storage Services, American CryoStem is also actively engaged in the production of a proprietary line of anti-aging, autologous skin care products; the marketing and licensing of its proprietary, patented tissue culture media products; and the identification and pursuit of partnering and licensing opportunities that will fully capitalize on the strengths of our IP and turnkey Adipose Tissue Processing Platform.

Branded, Proprietary Products, Services & Technologies

CELLECT™ Cellular Collection and Storage Service -- a clinical solution for physicians to acepticitally collect and deliver tissue samples utilizing proprietary and patent-pending methods and materials. The service creates an unbreakable “chain of custody” between physician/client and ACS Laboratories. The Cellect service is monitored in real-time and assures the highest cell viability upon laboratory receipt. Our collection/processing/storage pricing model provides for an initial collection and processing fee ranging from $750 to $2500, depending upon the volume of tissue and the desired processing and testing services required. The annual storage fee charged to an individual is based upon the type of material being
cryo-preserved (adipose tissue or ADRCs), the total volume and the storage configuration. The minimum storage fee is $200 per year. There are currently over 35 medical practices, and counting, across the United States now offering the Company’s adipose tissue and ADRC collection, processing and storage services.

ATGRAFT™ Adipose Tissue Storage Service – a clinical solution for physicians to provide their patients with the highest quality fat transfer and body sculpting procedures and storage technologies. The ATGRAFT Service permits individual  atients to benefit by using their own stored adipose tissue as a natural biocompatible filler for procedures without the trauma of further liposuctions. ATGRAFT procedures include breast augmentation, buttocks enhancement or volume corrections in the hands, face and neck.

American CryoStem is also engaged in marketing, selling and licensing our patented human-based tissue culture media products under the trademark ACSelerate™. The most widely used medium today for storing and growing stem cell cultures for in vitro diagnostics and research use is fetal bovine serum, raising questions about utilizing animals for the medium as well as generating debates relating to potential cross-contamination. We have pioneered and patented a new cell culture medium for growing human stromal cells (including all cells found in human skin, fat and other connective tissue) that is animal product free and suitable for human clinical and therapeutic uses.

More specifically, ACS Laboratories has been granted patent number 7,989,205 “Cell Culture Media, Kits and Methods of Use” (August 2, 2011). The granted claims include “A cell culture medium for clinical growth of human adipose stromal cells for human clinical and therapeutic applications.” The granted claims also include variations for cellular differentiation of adipose derived stem cells into osteoblasts (bone), chondrocytes (cartilage), adipocytes (fat), neural cells, smooth muscles cells in both HSA (clinical) grade and FBS (research) grade. This patent covers both non-GMP research grades and GMP clinical grades suitable for cell culture of adipose-derived mesenchymal stem cells intended for use in humans.

Company Service Overview video

Financial Information:  (Interview From Access Hollywood of Suzanne Somers Speaking about how Her Own Adipose Tissue was able to Regrow Her Breast after Cancer/Mastectomy

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CRYO News: Quarterly Report (10-q) 08/22/2016 04:06:21 PM
CRYO News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/15/2016 09:58:59 AM
CRYO News: Quarterly Report (10-q) 05/23/2016 04:05:40 PM
CRYO News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/16/2016 10:03:46 AM
#591   28,000 on the bid !! thetinman 10/21/16 01:07:19 PM
#590   American Cryostem Enters Into Agreement To License ACSelerate-Max biotechfunder 10/03/16 12:56:19 PM
#589   looks like some exciting things are happening with thetinman 09/28/16 11:14:27 AM
#588   good news story and looks like all buying .. thetinman 09/27/16 09:44:11 AM
#587   look like some thing are happening w/ this thetinman 09/26/16 08:03:59 PM
#586   American CryoStem to Participate in World Medical Tourism thetinman 09/26/16 08:40:43 AM
#585   Bid and ask look like they're starting to thetinman 09/21/16 06:04:01 PM
#584   (IMO) there is something up here.. the Stock thetinman 09/16/16 09:15:02 AM
#583   looks like the bid and ask are getting closer.. thetinman 09/14/16 10:23:45 AM
#582   bids look like they're start to build.. thetinman 09/12/16 01:22:08 PM
#581   looks like this stock is ready to move thetinman 09/10/16 10:01:39 AM
#580   thank you for selling me your shares !! thetinman 09/09/16 10:57:42 AM
#579   i'll be picking some shares up today and Monday.. thetinman 09/09/16 09:03:39 AM
#578   interesting concept... thetinman 09/08/16 03:59:48 PM
#577   Stem Cell Banking Market: $3.96 billion by 2021 sweet crude 07/25/16 11:07:46 AM
#576   CRYO stem cell storage (article) sweet crude 07/21/16 08:55:06 AM
#575   going under a penny---imo joanofarc 05/04/16 10:25:29 AM
#574   Kinda fizzled after report, keeping it on Radar trader_ron 04/20/16 01:08:57 PM
#573   BIG ADDITION TO $CRYO BOARD - NOBEL PRIZE biotechfunder 04/14/16 08:49:44 AM
#572   $CRYO GlobeSmallCap Research Report, "Digging in the Hyper trader_ron 04/12/16 07:39:34 AM
#571   $CRYO GlobeSmallCap Research Report, "Digging in the Hyper trader_ron 04/12/16 07:39:34 AM
#570   they need funding-500K in default joanofarc 04/04/16 10:52:04 AM
#569   no longer QB--going concern looks bad--this seems like joanofarc 03/01/16 10:28:14 AM
#568   I checked and that statement has been in biotechfunder 01/15/16 10:47:11 AM
#567   Yr end financial. say may be fraudulent funding joanofarc 01/14/16 02:45:33 PM
#566   this is fair--no 8K on acquisition joanofarc 05/17/15 05:53:20 PM
#565   American CryoStem Announces Acquisition of Biolife Cell Bank biotechfunder 04/20/15 09:15:15 AM
#564   Looks like another push back into the .60s biotechfunder 02/11/15 11:26:52 PM
#563   Adding American Cryostem To Watch List. Roland Rick Perry 02/02/15 10:07:30 AM
#562   Just looked, there is a yield sign, not biotechfunder 01/13/15 02:23:27 PM
#561   does anybody know whats happening here---no news stock joanofarc 12/31/14 10:00:52 AM
#560   sounds good-but no real revenue joanofarc 11/04/14 10:34:40 AM
#559   sounds good-but no real revenue joanofarc 11/04/14 10:34:17 AM
#558   $CRYO DD Notes ~ stocktrademan 10/30/14 12:29:49 PM
#557   Some new press coverage on CRYO's fat storage biotechfunder 10/03/14 10:00:15 AM
#556   Mission Statement SchragerTrader23 05/09/14 03:28:03 PM
#555   A patented enhanced cell culture basal medium containing budfoxhub 05/09/14 03:11:36 PM
#554   The Company maintains a strong, strategic portfolio of SchragerTrader23 05/09/14 03:05:10 PM
#553   A pioneer in the fields of Regenerative and SchragerTrader23 05/09/14 03:04:46 PM
#552   Low floater here, patience needed here for a breakout budfoxhub 05/09/14 02:34:55 PM
#551   American CryoStem Corporation (OTCQB: CRYO) is a pioneer Cabroncita 05/09/14 02:13:37 PM
#550   The 52-week high is $1.25. Radar $CRYO 05/09/14 01:41:12 PM
#549   American CryoStem Announces Breakthroughs in the Expansion and budfoxhub 05/09/14 12:39:10 PM
#548   The Company maintains a strong, strategic portfolio of Cabroncita 05/09/14 12:24:21 PM
#547   American CryoStem Corporation (OTCQB: CRYO) is a pioneer NYC Trader 05/09/14 11:55:53 AM
#546   Clinical Application Development - Together with our biotechnology Cabroncita 05/09/14 11:08:35 AM
#545   Check out the previous news on $CRYO, here NYC Trader 05/09/14 11:05:03 AM
#544   This is still holding up well. 56% Strong 05/09/14 11:02:14 AM
#543   CRYO updated Cheatsheet NYC Trader 05/09/14 10:06:21 AM
#542   You don't want to miss out on $CRYO. 05/09/14 09:33:46 AM